Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Michael J. Harvey"'
Autor:
Michael J. Harvey, Yi Zhong, Eric Morris, Jacob N. Beverage, Robert S. Epstein, Anita J. Chawla
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Subcutaneous (SC) administration of rituximab provides an opportunity for reduced patient treatment burden and increased healthcare efficiencies as an alternative to intravenous (IV) rituximab. There is minimal evidence comparing costs associated wit
Externí odkaz:
https://doaj.org/article/4d8465c0fcd94518be20434a00262695
Autor:
Michael J. Harvey, Howard G. Rosenthal
Publikováno v:
Case Reports in Oncological Medicine, Vol 2021 (2021)
Malignant musculoskeletal tumors about the shoulder girdle region involving the scapula are fairly rare, but when diagnosed, challenging and complex surgical treatment may be warranted with the primary goal of improving patient survival. These tumors
Externí odkaz:
https://doaj.org/article/9378ff98dc4e47278dcb6565388fd21b
Autor:
Joshua Neff, Seth M. Holmes, Kelly R. Knight, Shirley Strong, Ariana Thompson-Lastad, Cara McGuinness, Laura Duncan, Nimish Saxena, Michael J. Harvey, Alice Langford, Katiana L. Carey-Simms, Sara N. Minahan, Shannon Satterwhite, Caitlin Ruppel, Sonia Lee, Lillian Walkover, Jorge De Avila, Brett Lewis, Jenifer Matthews, Nicholas Nelson
Publikováno v:
MedEdPORTAL, Vol 16 (2020)
Introduction Research on disparities in health and health care has demonstrated that social, economic, and political factors are key drivers of poor health outcomes. Yet the role of such structural forces on health and health care has been incorporat
Externí odkaz:
https://doaj.org/article/bf3c41de9e844ff292079cd112573c45
Autor:
Rachel Cunningham, Michael J. Harvey, Meagan Montesion, Ali McBride, Bethany Sawchyn, Anita Chawla, Prasanth Reddy
Publikováno v:
JCO Precision Oncology. :1611-1624
PURPOSE This study assessed the economic impact of increased use of comprehensive genomic profiling (CGP) versus conventional testing strategies among patients with advanced non–small-cell lung cancer (aNSCLC) from a US commercial health plan persp
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156737 (2016)
To determine the optimal level of vaccination coverage defined as the level that minimizes total costs and explore how economic results change with marginal changes to this level of coverage.A susceptible-infected-recovered-vaccinated model designed
Externí odkaz:
https://doaj.org/article/4cddab9de7234b44b31cfd356f84ade5
Autor:
Howard G. Rosenthal, Michael J Harvey
Publikováno v:
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine, Vol 2021 (2021)
Case Reports in Oncological Medicine, Vol 2021 (2021)
Malignant musculoskeletal tumors about the shoulder girdle region involving the scapula are fairly rare, but when diagnosed, challenging and complex surgical treatment may be warranted with the primary goal of improving patient survival. These tumors
Autor:
Emma M. Harding-Esch, Michael J. Harvey, S Tariq Sadiq, Georgie Weston, Elisabeth J Adams, Claire Broad, Susie E Huntington
Publikováno v:
Eurosurveillance
Background Widespread ceftriaxone antimicrobial resistance (AMR) threatens Neisseria gonorrhoeae (NG) treatment, with few alternatives available. AMR point-of-care tests (AMR POCT) may enable alternative treatments, including abandoned regimens, spar
Publikováno v:
Pain. 161(2)
Our objective was to develop comprehensive national estimates of the total burden of herpes zoster (HZ) among U.S. adults, including direct (ie, medical costs) and indirect (ie, productivity losses) costs, as well as its psychosocial impact (ie, qual
Publikováno v:
Value in Health Regional Issues. 22:S75
Autor:
Caroline Dombrowski, Elisabeth J Adams, Maria Kyrgiou, Michael J. Harvey, Thomas Iftner, Georgie Weston, Christina Founta
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 3 (2020)
BMJ Open, Vol 10, Iss 3 (2020)
ObjectiveTo estimate the impact of using the Aptima messenger RNA (mRNA) high-risk human papilloma virus (HR-HPV) assay versus a DNA HR-HPV assay in a primary HPV cervical screening programme.DesignOne hypothetical cohort followed for 3 years through